Nitroaspirin
Catalog No. A19145
Nitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1.
Catalog Num | A19145 |
---|---|
M. Wt | 331.28 |
Formula | C16H13NO7 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 175033-36-0 |
Synonyms | 0 |
SMILES | O=C(OC1=CC=CC(CO[N+]([O-])=O)=C1)C2=CC=CC=C2OC(C)=O |
Nitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 30.19 mL | 150.93 mL | 301.86 mL |
0.5 mM | 6.04 mL | 30.19 mL | 60.37 mL |
1 mM | 3.02 mL | 15.09 mL | 30.19 mL |
5 mM | 0.6 mL | 3.02 mL | 6.04 mL |
*The above data is based on the productmolecular weight 331.28. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.